Data / Research funding / Texas / Base Pair Biotechnologies, Inc.
Base Pair Biotechnologies, Inc.: 4 NIH awards ($2.9M), fiscal years 2021 to 2026
Base Pair Biotechnologies, Inc. in Pearland, TX is funded under 4 NIH awards ($2.9M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- FFAKKLCKBNN7
- State
- Texas
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,763,772 | September 15, 2023 | July 31, 2027 | JACKSON, GEORGE W | reporter.nih.gov |
| Neonatal Opioid Screening Using Aptamers and Compensated Interferometry | NIH | National Institute on Drug Abuse | 2021 | $559,883 | March 1, 2019 | July 31, 2023 | JACKSON, GEORGE W | reporter.nih.gov |
| APTASENSORS FOR MEASURING LONG TERM ADHERENCE TO TENOFOVIR-BASED AND LONG ACTING HIV TREATMENT REGIMENS | NIH | National Institute on Drug Abuse | 2024 | $300,000 | September 15, 2024 | September 14, 2025 | JACKSON, GEORGE W | reporter.nih.gov |
| Aptamer engineering of lentiviral vectors for cardiac gene therapies | NIH | National Heart, Lung, and Blood Institute | 2023 | $289,665 | August 11, 2023 | June 30, 2024 | JACKSON, GEORGE W | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 1 | $746,175 | 0 | $0 |
| 2024 | 2 | $1,051,525 | 0 | $0 |
| 2023 | 2 | $555,737 | 0 | $0 |
| 2021 | 1 | $559,883 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) | PAR-24-089 | NIH | 93.279 | November 13, 2026 | $750,000 | Same assistance listing 93.279 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.279 | November 16, 2026 | $50,000 | Same assistance listing 93.279 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.279 | November 18, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.279 | November 18, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.279 | November 24, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.279 | December 3, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.279 | December 3, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.279 | December 4, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.279 | January 5, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.279 | January 5, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.279 | January 7, 2027 | $375,000 | Same assistance listing 93.279 as 1 award here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.279 | January 7, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.279 | January 7, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) | PAR-27-105 | NIH | 93.286 | January 25, 2027 | Not listed | Same assistance listing 93.286 as 1 award here |
| HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) | RFA-DA-28-011 | NIH | 93.279 | January 26, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) | RFA-DA-28-012 | NIH | 93.279 | January 26, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) | PAR-24-268 | NIH | 93.279 | January 27, 2027 | $500,000 | Same assistance listing 93.279 as 1 award here |
| BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) | RFA-NS-24-031 | NIH | 93.279 | January 28, 2027 | $750,000 | Same assistance listing 93.279 as 1 award here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.837 | February 3, 2027 | $1.5 million | Same assistance listing 93.837 as 1 award here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-25-026 | NIH | 93.837 | February 3, 2027 | Not listed | Same assistance listing 93.837 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.